Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease

Recruiting

• Conditions: Hernia; Gastric Ulcer; Hemorrhoids; Inflammatory Bowel Diseases; Colorectal Cancer; Gastric Cancer
• Interventions: Other: No intervention will be given to patients.

• Registration Number: NCT03972956
• Lead Sponsor: Renmin Hospital of Wuhan University

Brief Summary

The purposes of this study are to collect and store samples including blood, normal and tumor tissue from patients with colorectal cancer or gastric cancer, to collect and store samples including blood and/or normal gastrointestinal tissue (if available) from patients with non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD), gastric ulcer, hemorrhoids or hernia), and to create a database for the collected samples and allow access to relevant clinical information for current and future protocols.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-05-30
• Study First Submitted QC: 2019-05-31
• Study First Posted: 2019-06-04
• Study Start: 2020-12-23
• Status Verified: 2022-04
• Last Update Submitted: 2022-04-28
• Last Update Posted: 2022-04-29
• Primary Completion: 2023-12-23
• Study Completion: 2026-12-23

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Any patient diagnosed with colorectal cancer, gastric cancer, non-malignant disease that requires undergoing surgery.
• Must be willing and able to provide informed consent.

Exclusion Criteria

• Subjects whose comorbidities would preclude diagnostic or therapeutic intervention.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Colorectal cancer or gastric cancer patient	No intervention will be given to patients.	Patients suffering from CRC or gastric cancer scheduled to have surgical resection of colon/rectum or stomach.
Non-malignant disease patient	No intervention will be given to patients.	Patients suffering from non-malignant disease scheduled to have surgery.

Primary Outcome Measures

Name	Time	Method
Confirmation of diagnosis by pathologist	Up to 3 years	Once tissue is collected, those samples that have a confirmed diagnosis of disease by the pathologist will be used.

Trial Locations

Locations (1)

Department of Gastrointestinal Surgery II, Renmin Hospital of Wuhan University; 🇨🇳 Wuhan, Hubei, China